Vimarsana
Biggest News Aggregation in the World

Page 19 - Smith Kline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Smith Kline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Smith Kline Today - Breaking & Trending Today

BLOOMBERG On The Move March 17, 2016 - Vimarsana News

BLOOMBERG On The Move March 17, 2016

Careful. Welcome to the program program. It looks like it will be a fairly strong one for european equities. It will be opening up around 9 10 of 1 on the euro stocks. Whole bunch of stocks this morning. That will affect the market. The cac 40 and the dax up by 8 10 of 1 . The mattel he what else is going on around the world. The big move in the eurodollar. Where we are trading. Look whats happening to the kiwi as well. Here is the story were going to get into. Youre watching the story in brazil. Look at what crude is doing. Nymex is trading up over 2 . Here is the bloomberg first word news. T...

ALJAZAM Inside Story October 2, 2015 - Vimarsana News

ALJAZAM Inside Story October 2, 2015

Welcome to inside story. Im ray suarez. In the past few weeks, americans have been treated to the spectacle of an unapologetic corporate chief confidentably justifying his decision to take a 62yearold drug and start charging 50 times its regular price from 13. 50 to 750. The drug startup made mar sti mn strel lrvelli look like glax glh kline, look like a poster boy. Since it has no counterpart, its developer, touring pharmaceuticals, can charge what they want. Even by a factor of 50. Successful drug company, profitable drug company. I see where it looks greedy but there are a lot offal trui f ...

ALJAZAM Inside Story October 2, 2015 - Vimarsana News

ALJAZAM Inside Story October 2, 2015

Some people are stopping pills, medications altogether. Is there going to be a desire for shareholder value, prescriptions and profits . Its the inside story. Welcome to inside story. Im ray suarez. In the past few weeks, americans have been treated to the spectacle of an unapologetic corporate chief confidentably justifying his decision to take a 62yearold drug and start charging 50 times its regular price from 13. 50 to 750. The drug startup made mar stin martin strel lrv elli look like gla glaxo smith kline, look like a poster boy. Since it has no counterpart, its developer, touring pharmac...

KQED Nightly Business Report October 20, 2015 - Vimarsana News

KQED Nightly Business Report October 20, 2015

Making hardware into cloud computing. Ibm reported earnings of 3. 34 a share. That was four cents better than estimates. Thats the good news. But revenue fell nearly 14 from a year ago, coming in at 19. 28 billion. And that sent shares of the dow component initially lower in afterhours trading. In an interview after the results were released ibms cfo talked about the decline in revenue. Within the revenue we report we obviously have a pretty substantial currency headwind that we continue to deal with. And as we transform our business we continue to move out of areas where we dont see longterm ...

KQEH Nightly Business Report October 20, 2015 - Vimarsana News

KQEH Nightly Business Report October 20, 2015

Making hardware into cloud computing. Ibm reported earnings of 3. 34 a share. That was four cents better than estimates. Thats the good news. But revenue fell nearly 14 from a year ago, coming in at 19. 28 billion. And that sent shares of the dow component initially lower in afterhours trading. In an interview after the results were released ibms cfo talked about the decline in revenue. Within the revenue we report we obviously have a pretty substantial currency headwind that we continue to deal with. And as we transform our business we continue to move out of areas where we dont see longterm ...